134 related articles for article (PubMed ID: 9577694)
1. [The role of dynamic observation in the prevention of recurrences of stone formation].
Dzeranov NK; Darenkov AF; Konstantinova OV; Beshliev DA; Borisik VI; Golovanov SA; Drozhzheva VV
Urol Nefrol (Mosk); 1998; (2):12-4. PubMed ID: 9577694
[TBL] [Abstract][Full Text] [Related]
2. [Role of biochemical methods in follow-up and treatment of patients with urolithiasis].
Dzeranov NK; Konstantinova OV; Beshliev DA; Golovanov SA; Drozhzheva VV
Urologiia; 2001; (1):18-20. PubMed ID: 11233224
[TBL] [Abstract][Full Text] [Related]
3. [The most important factor for active urinary stone formation in patients with urolithiasis].
Simić-Ogrizović S; Dopsaj V; Jovicić S; Milenković D; Jovanović D; Nesić V
Med Pregl; 2007; 60 Suppl 2():117-20. PubMed ID: 18928175
[TBL] [Abstract][Full Text] [Related]
4. [The role of urinary excretion of magnesium in patients with urolithiasis with special respect to recurrence rate of stone formation (author's transl)].
Zechner O; Latal D
Urologe A; 1978 Jul; 17(4):258-60. PubMed ID: 684999
[TBL] [Abstract][Full Text] [Related]
5. [A metabolic approach to patients with calculi].
Wildschutz T; Ekane S; Simon J; Schulman CC
Acta Urol Belg; 1997 Oct; 65(3):9-14. PubMed ID: 9471888
[TBL] [Abstract][Full Text] [Related]
6. Pediatric urolithiasis--evaluation of risk factors in 95 children.
Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
[TBL] [Abstract][Full Text] [Related]
7. Local factors compared with systemic factors in the formation of bladder uric acid stones.
Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cystine urolithiasis by a combination of extracorporeal shock wave lithotripsy and chemolysis.
Ahlstrand C; Tiselius HG
J Stone Dis; 1993 Jan; 5(1):32-8. PubMed ID: 10148259
[TBL] [Abstract][Full Text] [Related]
9. [Recurrence-free and recurrent urolithiasis: metabolic differences].
Konstantinova OV; Ianenko EK; Dzeranov NK
Urologiia; 1999; (5):8-9. PubMed ID: 11150160
[TBL] [Abstract][Full Text] [Related]
10. [The role of phytotherapy in pre- and postoperative period in patients with urolithiasis].
Dzeranov NK; Konstantinova OV; Moskalenko SA; Beshliev DA; Butin PS; Drozhzheva VV; Kon'kova TA
Urologiia; 2005; (2):18-20. PubMed ID: 15989020
[TBL] [Abstract][Full Text] [Related]
11. Retrograde ureteropyeloscopic treatment of 2 cm. or greater upper urinary tract and minor Staghorn calculi.
Grasso M; Conlin M; Bagley D
J Urol; 1998 Aug; 160(2):346-51. PubMed ID: 9679874
[TBL] [Abstract][Full Text] [Related]
12. [Personal experience in the diagnosis and monitoring of therapy in metabolic disorders with risk of crystallization in patients with recurrent urolithiasis].
Stejskal D; Bártek J; Hrebícek J; Bána J; Zát'ura F; Mohapl P; Terber R
Vnitr Lek; 1997 Dec; 43(12):781-6. PubMed ID: 9601889
[TBL] [Abstract][Full Text] [Related]
13. Prevention of stone disease.
Porena M; Guiggi P; Micheli C
Urol Int; 2007; 79 Suppl 1():37-46. PubMed ID: 17726351
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal shockwave lithotripsy in infants.
Ramakrishnan PA; Medhat M; Al-Bulushi YH; Nair P; Al-Kindy A
Can J Urol; 2007 Oct; 14(5):3684-91. PubMed ID: 17949522
[TBL] [Abstract][Full Text] [Related]
15. [Age of onset of urolithiasis: relation to clinical and metabolic risk factors].
Lancina Martín JA; Novás Castro S; Rodríguez-Rivera García J; Ruibal Moldes M; Blanco Díez A; Fernández Rosado E; Barbagelata López A; González Martín M
Arch Esp Urol; 2004 Mar; 57(2):119-25. PubMed ID: 15074780
[TBL] [Abstract][Full Text] [Related]
16. Urinary metabolic evaluations in solitary and recurrent stone forming children.
DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
[TBL] [Abstract][Full Text] [Related]
17. Screening for biochemical abnormalities in urolithiasis patients.
Orakzai N; Hanbury DC; Farrington K
J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
[TBL] [Abstract][Full Text] [Related]
18. Metabolic evaluation and medical management of upper urinary tract stone disease. Guidelines from the Scandinavian Cooperative Group for Urinary Stones.
Osther PJ; Grenabo L; Haraldsson G; Holmberg G; Lindell O; Mogensen P; Schultz A; Ulvik NM
Scand J Urol Nephrol; 1999 Dec; 33(6):372-81. PubMed ID: 10636576
[TBL] [Abstract][Full Text] [Related]
19. [The role of agregatometry in diagnosis of urolithiasis].
Kadyrov ZA; Istratov VG; Suleĭmanov SI; Ramishvili VSh
Urologiia; 2007; (1):36-40. PubMed ID: 17471996
[TBL] [Abstract][Full Text] [Related]
20. Hounsfield unit density accurately predicts ESWL success.
Magnuson WJ; Tomera KM; Lance RS
Alaska Med; 2005; 47(2):6-9. PubMed ID: 16459477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
